Crinetics Pharmaceuticals (CRNX) Receivables - Accured (2022 - 2025)
Historic Receivables - Accured for Crinetics Pharmaceuticals (CRNX) over the last 4 years, with Q3 2025 value amounting to $6.3 million.
- Crinetics Pharmaceuticals' Receivables - Accured changed N/A to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $8.3 million for FY2024, which is 16774.19% up from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Receivables - Accured stood at $6.3 million for Q3 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' Receivables - Accured peaked at $8.4 million during Q2 2025, and registered a low of $1.4 million during Q4 2022.
- In the last 4 years, Crinetics Pharmaceuticals' Receivables - Accured had a median value of $6.8 million in 2025 and averaged $5.8 million.
- In the last 5 years, Crinetics Pharmaceuticals' Receivables - Accured surged by 12142.86% in 2023 and then soared by 16774.19% in 2024.
- Crinetics Pharmaceuticals' Receivables - Accured (Quarter) stood at $1.4 million in 2022, then soared by 121.43% to $3.1 million in 2023, then soared by 167.74% to $8.3 million in 2024, then fell by 24.1% to $6.3 million in 2025.
- Its Receivables - Accured stands at $6.3 million for Q3 2025, versus $8.4 million for Q2 2025 and $7.2 million for Q1 2025.